Omega-3 fatty acids and skeletal muscle health

Marine Drugs

Volumn 13, Issue 11, 2015, Pages 6977-7004

  Jeromson, Stewart ^a   Gallagher, Iain J ^a   Galloway, Stuart D R ^a   Hamilton, D Lee ^a  

^a UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Fish oil; Hypertrophy and diabetes; Omega 3 fatty acids; Skeletal muscle

Indexed keywords

DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

DIET SUPPLEMENTATION; FAT INTAKE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPIDOMICS; METABOLIC FLEXIBILITY; METABOLIC PARAMETERS; METABOLIC REGULATION; MUSCLE FUNCTION; MUSCLE METABOLISM; NONHUMAN; REVIEW; SKELETAL MUSCLE; THERAPY EFFECT; AGING; ANIMAL; AQUATIC SPECIES; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM;

AGING; ANIMALS; AQUATIC ORGANISMS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; MUSCLE, SKELETAL;

EID: 84958949143     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13116977     Document Type: Review

References (175)

1. Schmidt, M.; Johannesdottir, S.A.; Lemeshow, S.; Lash, T.L.; Ulrichsen, S.P.; Botker, H.E.; Toft Sorensen, H. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: A Danish 33-year follow-up study. BMJ Open 2013, 3, e002698, doi:10.1136/bmjopen-2013-002698.
2. Meyer, C.; Dostou, J.M.; Welle, S.L.; Gerich, J.E. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 2002, 282, E419-E427.
3. Zhao, X.; Wang, Z.; Zhang, J.; Hua, J.; He, W.; Zhu, S. Estimation of total body skeletal muscle mass in Chinese adults: Prediction model by dual-energy X-ray absorptiometry. PLoS ONE 2013, 8, e53561, doi:10.1371/journal.pone.0053561.
4. Kim, J.; Wang, Z.; Heymsfield, S.B.; Baumgartner, R.N.; Gallagher, D. Total-body skeletal muscle mass: Estimation by a new dual-energy X-ray absorptiometry method. Am. J. Clin. Nutr. 2002, 76, 378-383.
5. Rosenberg, I.H. Sarcopenia: Origins and clinical relevance. J. Nutr. 1997, 127, 990S-991S.
6. Wolfe, R.R. The underappreciated role of muscle in health and disease. Am. J. Clin. Nutr. 2006, 84, 475-482.
7. Kyle, U.G.; Genton, L.; Hans, D.; Karsegard, L.; Slosman, D.O.; Pichard, C. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur. J. Clin. Nutr. 2001, 55, 663-672.
8. Roubenoff, R. Sarcopenia: Effects on body composition and function. J. Gerontol. A Biol. Sci. Med. Sci. 2003, 58, 1012-1017.
9. Janssen, I.; Shepard, D.S.; Katzmarzyk, P.T.; Roubenoff, R. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 2004, 52, 80-85.
10. Smith, G.I.; Julliand, S.; Reeds, D.N.; Sinacore, D.R.; Klein, S.; Mittendorfer, B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am. J. Clin. Nutr. 2015, 102, 115-122.
11. Rodacki, C.L.N.; Rodacki, A.L.F.; Pereira, G.; Naliwaiko, K.; Coelho, I.; Pequito, D.; Fernandes, L.C. Fish-oil supplementation enhances the effects of strength training in elderly women. Am. J. Clin. Nutr. 2012, 95, 428-436.
12. Vessby, B.; Uusitupa, M.; Hermansen, K.; Riccardi, G.; Rivellese, A.A.; Tapsell, L.C.; Nälsén, C.; Berglund, L.; Louheranta, A.; Rasmussen, B.M.; et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001, 44, 312-319.
13. Summers, L.K.M.; Fielding, B.A.; Bradshaw, H.A.; Ilic, V.; Beysen, C.; Clark, M.L.; Moore, N.R.; Frayn, K.N. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002, 45, 369-377.
14. Rees, K.; Hartley, L.; Flowers, N.; Clarke, A.; Hooper, L.; Thorogood, M.; Stranges, S. "Mediterranean" dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013, 8, CD009825, doi:10.1002/14651858.CD009825.pub2.
15. Esposito, K.; Marfella, R.; Ciotola, M.; Di Palo, C.; Giugliano, F.; Giugliano, G.; Giugliano, D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 2004, 292, 1440-1446.
16. Ebbesson, S.O.E.; Ebbesson, L.O.E.; Swenson, M.; Kennish, J.M.; Robbins, D.C. A successful diabetes prevention study in Eskimos: The Alaska Siberia project. Int. J. Circumpolar Health 2005, 64, 409-424.
17. Bang, H.O.; Dyerberg, J.; Sinclair, H.M. The composition of the Eskimo food in north western Greenland. Am. J. Clin. Nutr. 1980, 33, 2657-2661.
18. Siriwardhana, N.; Kalupahana, N.S.; Fletcher, S.; Xin, W.; Claycombe, K.J.; Quignard-Boulange, A.; Moustaid-Moussa, N. n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-κB-dependent mechanisms. J. Nutr. Biochem. 2012, 23, 1661-1667.
19. Dimopoulos, N.; Watson, M.; Sakamoto, K.; Hundal, H.S. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem. J. 2006, 399, 473-481.
20. Burdge, G.C.; Calder, P.C. Introduction to fatty acids and lipids. World Rev. Nutr. Diet. 2015, 112, 1-16.
21. Andersson, A.; Nälsén, C.; Tengblad, S.; Vessby, B. Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. Am. J. Clin. Nutr. 2002, 76, 1222-1229.
22. Dangardt, F.; Chen, Y.; Gronowitz, E.; Dahlgren, J.; Friberg, P.; Strandvik, B. High physiological omega-3 Fatty Acid supplementation affects muscle Fatty Acid composition and glucose and insulin homeostasis in obese adolescents. J. Nutr. Metab. 2012, 2012, 395757, doi:10.1155/2012/395757.
23. McGlory, C.; Galloway, S.D.R.; Hamilton, D.L.; McClintock, C.; Breen, L.; Dick, J.R.; Bell, J.G.; Tipton, K.D. Temporal changes in human skeletal muscle and blood lipid composition with fish oil supplementation. Prostaglandins Leukot. Essent. Fatty Acids 2014, 90, 199-206.
24. Glatz, J.F.; Luiken, J.J.; Bonen, A. Membrane fatty acid transporters as regulators of lipid metabolism: Implications for metabolic disease. Physiol. Rev. 2010, 90, 367-417.
25. Holloway, G.P.; Bezaire, V.; Heigenhauser, G.J.; Tandon, N.N.; Glatz, J.F.; Luiken, J.J.; Bonen, A.; Spriet, L.L. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J. Physiol. 2006, 571 201-210.
26. Dyck, D.J.; Peters, S.J.; Glatz, J.; Gorski, J.; Keizer, H.; Kiens, B.; Bonen, A. Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am. J. Physiol. 1997, 272, E340-E351.
27. Los, D.A.; Murata, N. Membrane fluidity and its roles in the perception of environmental signals. Biochim. Biophys. Acta 2004, 1666, 142-157.
28. Holte, L.L.; Peter, S.A.; Sinnwell, T.M.; Gawrisch, K. 2H nuclear magnetic resonance order parameter profiles suggest a change of molecular shape for phosphatidylcholines containing a polyunsaturated acyl chain. Biophys. J. 1995, 68, 2396-2403.
29. Stillwell, W.; Wassall, S.R. Docosahexaenoic acid: Membrane properties of a unique fatty acid. Chem. Phys. Lipids 2003, 126, 1-27.
30. Stubbs, C.D.; Smith, A.D. Essential fatty acids in membrane: Physical properties and function. Biochem. Soc. Trans. 1990, 18, 779-781.
31. Burdge, G.C.; Jones, A.E.; Wootton, S.A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men∗. Br. J. Nutr. 2002, 88, 355-363.
32. Burdge, G.C.; Wootton, S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 2002, 88, 411-420.
33. Smink, W.; Gerrits, W.J.J.; Gloaguen, M.; Ruiter, A.; van Baal, J. Linoleic and α-linolenic acid as precursor and inhibitor for the synthesis of long-chain polyunsaturated fatty acids in liver and brain of growing pigs. Animal 2012, 6, 262-270.
34. Walker, C.G.; Jebb, S.A.; Calder, P.C. Stearidonic acid as a supplemental source of ω-3 polyunsaturated fatty acids to enhance status for improved human health. Nutrition 2013, 29, 363-369.
35. Nording, M.L.; Yang, J.; Georgi, K.; Hegedus Karbowski, C.; German, J.B.; Weiss, R.H.; Hogg, R.J.; Trygg, J.; Hammock, B.D.; Zivkovic, A.M. Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids. PLoS ONE 2013, 8, e76575, doi:10.1371/journal.pone.0076575.
36. Simopoulos, A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: Nutritional implications for chronic diseases. Biomed. Pharmacother. 2006, 60, 502-507.
37. Harris, W.S.; Mozaffarian, D.; Lefevre, M.; Toner, C.D.; Colombo, J.; Cunnane, S.C.; Whelan, J. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J. Nutr. 2009, 139, 804S-819S.
38. Harris, W.S. N-3 fatty acids and serum lipoproteins: Human studies. Am. J. Clin. Nutr. 1997, 65, 1645S-1654S.
39. Thifault, E.; Cormier, H.; Bouchard-Mercier, A.; Rudkowska, I.; Paradis, A.-M.; Garneau, V.; Vohl, M.-C. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J. Nutrigenet. Nutrigenomics 2013, 6, 73-82.
40. Hooper, L.; Thompson, R.L.; Harrison, R.A.; Summerbell, C.D.; Ness, A.R.; Moore, H.J.; Davey Smith, G. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: Systematic review. BMJ 2006, 332, 752-760.
41. Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1024-1033.
42. Djoussé, L.; Akinkuolie, A.O.; Wu, J.H.Y.; Ding, E.L.; Gaziano, J.M. Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis. Clin. Nutr. 2012, 31, 846-853.
43. Marik, P.E.; Varon, J. Omega-3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review. Clin. Cardiol. 2009, 32, 365-372.
44. Kang, J.X.; Wang, J.; Wu, L.; Kang, Z.B. Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427, 504, doi:10.1038/427504a.
45. Smith, B.K.; Holloway, G.P.; Reza-Lopez, S.; Jeram, S.M.; Kang, J.X.; Ma, D.W.L. A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance. Appl. Physiol. Nutr. Metab. 2010, 35, 699-706.
46. Romanatto, T.; Fiamoncini, J.; Wang, B.; Curi, R.; Kang, J.X. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice. Biochim. Biophys. Acta 2014, 1842, 186-191.
47. White, P.J.; Arita, M.; Taguchi, R.; Kang, J.X.; Marette, A. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes 2010, 59, 3066-3073.
48. Wei, D.; Li, J.; Shen, M.; Jia, W.; Chen, N.; Chen, T.; Zhao, A. Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death. Diabetes 2010, 59, 471-478.
49. Kaur, G.; Cameron-Smith, D.; Garg, M.; Sinclair, A.J. Docosapentaenoic acid (22:5n-3): A review of its biological effects. Prog. Lipid. Res. 2011, 50, 28-34.
50. Akiba, S.; Murata, T.; Kitatani, K.; Sato, T. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol. Pharm. Bull. 2000, 23, 1293-1297.
51. Kanayasu-Toyoda, T.; Morita, I.; Murota, S. Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostaglandins Leukot. Essent. Fatty Acids 1996, 54, 319-325.
52. Norris, P.C.; Dennis, E.A. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc. Natl. Acad. Sci. USA 2012, 109, 8517-8522.
53. Kamolrat, T.; Gray, S.R. The effect of eicosapentaenoic and docosahexaenoic acid on protein synthesis and breakdown in murine C2C12 myotubes. Biochem. Biophys. Res. Commun. 2013, 432 593-598.
54. Blasbalg, T.L.; Hibbeln, J.R.; Ramsden, C.E.; Majchrzak, S.F.; Rawlings, R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93, 950-962.
55. Schenk, S.; Saberi, M.; Olefsky, J.M. Insulin sensitivity: Modulation by nutrients and inflammation. J. Clin. Investig. 2008, 118, 2992-3002.
56. Phillips, S.M.; Tipton, K.D.; Aarsland, A.; Wolf, S.E.; Wolfe, R.R. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am. J. Physiol. 1997, 273, E99-E107.
57. Bodine, S.C. Disuse-induced muscle wasting. Int. J. Biochem. Cell Biol. 2013, 45, 2200-2208.
58. Ryan, A.M.; Reynolds, J.V, Healy, L.; Byrne, M.; Moore, J.; Brannelly, N.; Flood, P. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: Results of a double-blinded randomized controlled trial. Ann. Surg. 2009, 249, 355-363.
59. You, J.-S.; Park, M.-N.; Song, W.; Lee, Y.-S. Dietary fish oil alleviates soleus atrophy during immobilization in association with Akt signaling to p70s6k and E3 ubiquitin ligases in rats. Appl. Physiol. Nutr. Metab. 2010, 35, 310-318.
60. Alexander, J.W.; Saito, H.; Trocki, O.; Ogle, C.K. The importance of lipid type in the diet after burn injury. Ann. Surg. 1986, 204, 1-8.
61. Tipton, K.D.; Ferrando, A.A.; Phillips, S.M.; Doyle, D.; Wolfe, R.R. Postexercise net protein synthesis in human muscle from orally administered amino acids. Am. J. Physiol. 1999, 276, E628-E634.
62. Smith, G.I.; Atherton, P.; Reeds, D.N.; Mohammed, B.S.; Rankin, D.; Rennie, M.J.; Mittendorfer, B. Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women. Clin. Sci. (Lond.) 2011, 121, 267-278.
63. Smith, G.I.; Atherton, P.; Reeds, D.N.; Mohammed, B.S.; Rankin, D.; Rennie, M.J.; Mittendorfer, B. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: A randomized controlled trial. Am. J. Clin. Nutr. 2011, 93, 402-412.
64. Baar, K.; Esser, K. Phosphorylation of p70 (S6k) correlates with increased skeletal muscle mass following resistance exercise. Am. J. Physiol. 1999, 276, C120-C127.
65. Drummond, M.J.; Dreyer, H.C.; Fry, C.S.; Glynn, E.L.; Rasmussen, B.B. Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling. J. Appl. Physiol. (1985) 2009, 106, 1374-1384.
66. Huang, F.; Wei, H.; Luo, H.; Jiang, S.; Peng, J. EPA inhibits the inhibitor of κBα (IκBα)/NF-κB/muscle RING finger 1 pathway in C2C12 myotubes in a PPARγ-dependent manner. Br. J. Nutr. 2011, 105, 348-356.
67. Magee, P.; Pearson, S.; Allen, J. The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation. Lipids Health Dis. 2008, 7, 24, doi:10.1186/1476-511X-7-24.
68. Magee, P.; Pearson, S.; Whittingham-Dowd, J.; Allen, J. PPARγ as a molecular target of EPA anti-inflammatory activity during TNF-α-impaired skeletal muscle cell differentiation. J. Nutr. Biochem. 2012, 23, 1440-1448.
69. Kubota, H.; Matsumoto, H.; Higashida, M.; Murakami, H.; Nakashima, H.; Oka, Y.; Hirai, T. Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line. Anticancer Res. 2013, 33, 4319-4324.
70. Li, H.; Malhotra, S.; Kumar, A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J. Mol. Med. (Berl.) 2008, 86, 1113-1126.
71. Bodine, S.C.; Latres, E.; Baumhueter, S.; Lai, V.K.; Nunez, L.; Clarke, B.A.; Glass, D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294, 1704-1708.
72. Baehr, L.M.; Furlow, J.D.; Bodine, S.C. Muscle sparing in muscle RING finger 1 null mice: Response to synthetic glucocorticoids. J. Physiol. 2011, 589, 4759-4776.
73. Whitehouse, A.S.; Tisdale, M.J. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochem. Biophys. Res. Commun. 2001, 285, 598-602.
74. Wang, Y.; Lin, Q.; Zheng, P.; Zhang, J.; Huang, F. DHA inhibits protein degradation more efficiently than EPA by regulating the PPARγ/NFκB pathway in C2C12 myotubes. Biomed Res. Int. 2013, 2013, doi:10.1155/2013/318981.
75. Patten, G.S.; Abeywardena, M.Y.; McMurchie, E.J.; Jahangiri, A. Dietary fish oil increases acetylcholine- and eicosanoid-induced contractility of isolated rat ileum. J. Nutr. 2002, 132, 2506-2513.
76. Piasecki, M.; Ireland, A.; Stashuk, D.; Hamilton-Wright, A.; Jones, D.A.; McPhee, J.S. Age-related neuromuscular changes affecting human vastus lateralis. J. Physiol. 2015, doi:10.1113/JP271087.
77. You, J.-S.; Park, M.-N.; Lee, Y.-S. Dietary fish oil inhibits the early stage of recovery of atrophied soleus muscle in rats via Akt-p70s6k signaling and PGF2α. J. Nutr. Biochem. 2010, 21, 929-934.
78. Trappe, T.A.; Fluckey, J.D.; White, F.; Lambert, C.P.; Evans, W.J. Skeletal muscle PGF (2) (alpha) and PGE (2) in response to eccentric resistance exercise: Influence of ibuprofen acetaminophen. J. Clin. Endocrinol. Metab. 2001, 86, 5067-5070.
79. Trappe, T.A.; White, F.; Lambert, C.P.; Cesar, D.; Hellerstein, M.; Evans, W.J. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am. J. Physiol. Endocrinol. Metab. 2002, 282, E551-E556.
80. Cuthbertson, D.; Smith, K.; Babraj, J.; Leese, G.; Waddell, T.; Atherton, P.; Wackerhage, H; Taylor, P.M.; Rennie, M.J. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005, 19, 422-424.
81. Kamolrat, T.; Gray, S.R.; Thivierge, M.C. Fish oil positively regulates anabolic signalling alongside an increase in whole-body gluconeogenesis in ageing skeletal muscle. Eur. J. Nutr. 2013, 52, 647-657.
82. Gingra, A.A.; White, P.J.; Chouinard, P.Y.; Julien, P.; Davis, T.A.; Dombrowski, L.; Couture, Y.; Dubreuil, P.; Myre, A.; Bergeron, K.; et al. Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J. Physiol. 2007, 579, 269-284.
83. Phillips, B.E.; Hill, D.S.; Atherton, P.J. Regulation of muscle protein synthesis in humans. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 58-63.
84. Corpeleijn, E.; Mensink, M.; Kooi, M.E.; Roekaerts, P.M.H.J.; Saris, W.H.M.; Blaak, E.E. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 2008, 16, 1025-1032.
85. Blaak, E.E.; Wagenmakers, A.J.; Glatz, J.F.; Wolffenbuttel, B.H.; Kemerink, G.J.; Langenberg, C.J.; Heidendal, G.A.; Saris, W.H. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am. J. Physiol. Endocrinol. Metab. 2000, 279, E146-E154.
86. Kelley, D.E.; He, J.; Menshikova, E.V.; Ritov, V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51, 2944-2950.
87. Simoneau, J.-A.; Veerkamp, J.H.; Turcotte, L.P.; Kelley, D.E. Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss. FASEB J. 1999, 13, 2051-2060.
88. Hessvik, N.P.; Bakke, S.S.; Fredriksson, K.; Boekschoten, M.V, Fjørkenstad, A.; Koster, G.; Thoresen, G.H. Metabolic switching of human myotubes is improved by n-3 fatty acids. J. Lipid. Res. 2010, 51, 2090-2104.
89. Delarue, J.; Couet, C.; Cohen, R.; Bréchot, J.F.; Antoine, J.M.; Lamisse, F. Effects of fish oil on metabolic responses to oral fructose and glucose loads in healthy humans. Am. J. Physiol. 1996, 270, E353-E362.
90. Delarue, J.; Labarthe, F.; Cohen, R. Fish-oil supplementation reduces stimulation of plasma glucose fluxes during exercise in untrained males. Br. J. Nutr. 2003, 90, 777-786.
91. Bradley, N.S.; Heigenhauser, G.J.F.; Roy, B.D.; Staples, E.M.; Inglis, J.G.; LeBlanc, P.J.; Peters, S.J. The acute effects of differential dietary fatty acids on human skeletal muscle pyruvate dehydrogenase activity. J. Appl. Physiol. (1985) 2008, 104, 1-9.
92. Mostad, I.L.; Bjerve, K.S.; Bjorgaas, M.R.; Lydersen, S.; Grill, V. Effects of n-3 fatty acids in subjects with type 2 diabetes: Reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am. J. Clin. Nutr. 2006, 84, 540-550.
93. Figueras, M.; Olivan, M.; Busquets, S.; López-Soriano, F.J.; Argilés, J.M. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: Improvement of the inflammatory status. Obesity (Silver Spring) 2011, 19, 362-369.
94. Vaughan, R.A.; Garcia-Smith, R.; Bisoffi, M.; Conn, C.A.; Trujillo, K.A. Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells. Lipids Health Dis. 2012, 11, 142, doi:10.1186/1476-511X-11-142.
95. Patti, M.E.; Butte, A.J.; Crunkhorn, S.; Cusi, K.; Berria, R.; Kashyap, S.; Miyazaki, Y.; Kohane, I.; Costello, M.; Saccone, R.; et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 2003, 100, 8466-8471.
96. Hancock, C.R.; Han, D.-H.; Chen, M.; Terada, S.; Yasuda, T.; Wright, D.C.; Holloszy, J.O. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc. Natl. Acad. Sci. USA 2008, 105, 7815-7820.
97. Turner, N.; Bruce, C.R.; Beale, S.M.; Hoehn, K.L.; So, T.; Rolph, M.S.; Cooney, G.J. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: Evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007, 56, 2085-2092.
98. Trenell, M.I.; Hollingsworth, K.G.; Lim, E.L.; Taylor, R. Increased daily walking improves lipid oxidation without changes in mitochondrial function in type 2 diabetes. Diabetes Care 2008, 31, 1644-1649.
99. Van Tienen, F.H.; Praet, S.F.; de Feyter, H.M.; van den Broek, N.M.; Lindsey, P.J.; Schoonderwoerd, K.G.; de Coo, I.F.; Nicolay, K.; Prompers, J.J.; Smeets, H.J.; et al. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J. Clin. Endocrinol. Metab. 2012, 97, 3261-3269.
100. Lanza, I.R.; Blachnio-Zabielska, A.; Zabielski, P.; Nair, K.S.; Jensen, M.; Lebrasseur, N. Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2013, 304, E1391-E1403.
101. Jeng, J.-Y.; Lee, W.-H.; Tsai, Y.-H.; Chen, C.-Y.; Chao, S.-Y.; Hsieh, R.-H. Functional modulation of mitochondria by eicosapentaenoic acid provides protection against ceramide toxicity to C6 glioma cells. J. Agric. Food Chem. 2009, 57, 11455-11462.
102. Herbst, E.A.F.; Paglialunga, S.; Gerling, C.; Whitfield, J.; Mukai, K.; Chabowski, A.; Holloway, G.P. Omega-3 supplementation alters mitochondrial membrane composition and respiration kinetics in human skeletal muscle. J. Physiol. 2014, 592, 1341-1352.
103. Lalia, A.Z.; Johnson, M.L.; Jensen, M.D.; Hames, K.C.; Port, J.D.; Lanza, I.R. Effects of dietary n-3 fatty acids on hepatic and peripheral insulin sensitivity in insulin resistant humans. Diabetes Care 2015, 38, 1228-1237.
104. Johnson, M.L.; Lalia, A.Z.; Dasari, S.; Pallauf, M.; Fitch, M.; Hellerstein, M.K.; Lanza, I.R. Eicosapentaenoic acid but not docosahexaenoic acid restores skeletal muscle mitochondrial oxidative capacity in old mice. Aging Cell 2015, 14, 7343.
105. Matravadia, S.; Herbst, E.A.F.; Jain, S.S.; Mutch, D.M.; Holloway G.P. Both linoleic and α-linolenic acid prevent insulin resistance but have divergent impacts on skeletal muscle mitochondrial bioenergetics in obese Zucker rats. Am. J. Physiol. Endocrinol. Metab. 2014, 307 E102-E114.
106. Thiebaud, D.; Jacot, E.; DeFronzo, R.A.; Maeder, E.; Jequier, E.; Felber, J.P. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 1982, 31, 957-963.
107. Zierath, J.R.; Krook, A.; Wallberg-Henriksson, H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia 2000, 43, 821-835.
108. Damsbo, P.; Vaag, A.; Hother-Nielsen, O.; Beck-Nielsen, H. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991, 34, 239-245.
109. Cline, G.W.; Petersen, K.F.; Krssak, M.; Shen, J.; Hundal, R.S.; Trajanoski, Z.; Inzucchi, S.; Dresner, A.; Rothman, D.L.; Shulman, G.I. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N. Engl. J. Med. 1999, 341, 240-246.
110. Turner, N.; Kowalski, G.M.; Leslie, S.J.; Risis, S.; Yang, C.; Lee-Young, R.S.; Bruce, C.R. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 2013, 56, 1638-1648.
111. Roden, M.; Stingl, H.; Chandramouli, V.; Schumann, W.C.; Hofer, A.; Landau, B.R.; Nowotny, P.; Waldhäusl, W.; Shulman, G.I. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 2000, 49, 701-707.
112. Boden, G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc. Assoc. Am. Physicians. 1991, 111, 241-248.
113. Szendroedi, J.; Yoshimura, T.; Phielix, E.; Koliaki, C.; Marcucci, M.; Zhang, D.; Roden, M. Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc. Natl. Acad. Sci. USA 2014, 111, 9597-9602.
114. Stratford, S.; DeWald, D.B.; Summers, S.A. Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation. Biochem. J. 2001, 354, 359-368.
115. Ellis, B.A.; Poynten, A.; Lowy, A.J.; Furler, S.M.; Chisholm, D.J.; Kraegen, E.W.; Cooney, G.J. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol. Endocrinol. Metab. 2000, 279, E554-E560.
116. Itani, S.I.; Ruderman, N.B.; Schmieder, F.; Boden, G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51, 2005-2011.
117. Yu, C.; Chen, Y.; Cline, G. W.; Zhang, D.; Zong, H.; Wang, Y.; Shulman, G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 2002, 277, 50230-50236.
118. Chavez, J.A.; Knotts, T.A.; Wang, L.-P.; Li, G.; Dobrowsky, R.T.; Florant, G.L.; Summers, S.A. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem. 2003, 278, 10297-10303.
119. Powell, D.J.; Turban, S.; Gray, A.; Hajduch, E.; Hundal, H.S. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 2004, 382, 619-629
120. Stretton, C.; Evans, A.; Hundal, H.S. Cellular depletion of atypical PKCλ is associated with enhanced insulin sensitivity and glucose uptake in L6 rat skeletal muscle cells. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E402-E412.
121. Pedersen, O.; Bak, J.F.; Andersen, P.H.; Lund, S.; Moller, D.E.; Flier, J.S.; Kahn, B.B. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 1990, 39, 865-870.
122. Ryder, J.W.; Yang, J.; Galuska, D.; Rincón, J.; Björnholm, M.; Krook, A.; Holman, G.D. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000, 49, 647-654.
123. Wu, J.H.Y.; Micha, R.; Imamura, F.; Pan, A.; Biggs, M.L.; Ajaz, O.; Mozaffarian, D. Omega-3 fatty acids and incident type 2 diabetes: A systematic review and meta-analysis. Br. J. Nutr. 2012, 107, S214-S227.
124. Akinkuolie, A.O.; Ngwa, J.S.; Meigs, J.B.; Djoussé, L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials. Clin. Nutr. 2011, 30, 702-707.
125. Hartweg, J.; Perera, R.; Montori, V.; Dinneen, S.; Neil, H.A.W.; Farmer, A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2008, CD003205, doi:10.1002/14651858.CD003205.pub2.
126. Albert, B.B.; Derraik, J.G.; Brennan, C.M.; Biggs, J.B.; Smith, G.C.; Garg, M.L.; Cameron-Smith, D.; Hofman, P.L.; Cutfield, W.S. Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men. Sci. Rep. 2014, 4, 6697, doi:10.1038/srep06697.
127. Delarue, J.; Li, C.-H.; Cohen, R.; Corporeau, C.; Simon, B. Interaction of fish oil and a glucocorticoid on metabolic responses to an oral glucose load in healthy human subjects. Br. J. Nutr. 2006, 95, 267-272.
128. Popp-Snijders, C.; Schouten, J.A.; Heine, R.J.; van der Meer, J.; van der Veen, E.A. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res. 1987, 4, 141-147.
129. Fasching, P.; Ratheiser, K.; Waldhäusl, W.; Rohac, M.; Osterrode, W.; Nowotny, P.; Vierhapper, H. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 1991, 40, 583-589.
130. Glauber, H.; Wallace, P.; Griver, K.; Brechtel, G. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 1988, 108, 663-668.
131. Stephens, F.B.; Mendis, B.; Shannon, C.E.; Cooper, S.; Ortori, C.A.; Barrett, D.A.; Mansell, P.; Tsintzas, K. Fish oil omega-3 fatty acids partially prevent lipid-induced insulin resistance in human skeletal muscle without limiting acylcarnitine accumulation. Clin. Sci. (Lond.) 2014, 127, 315-322.
132. Aas, V.; Rokling-Andersen.; M.H.; Kase, E.T.; Thoresen, G.H.; Rustan, A.C. Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells. J. Lipid. Res. 2005, 47, 366-374.
133. Wensaas, A.J.; Rustan, A.C.; Just, M.; Berge, R.K.; Drevon, C.A.; Gaster, M. Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of oxidation products because of impaired fatty acid oxidation: Effects of tetradecylthioacetic acid and eicosapentaenoic acid. Diabetes 2008, 58, 527-535.
134. Barber, E.; Sinclair, A.J.; Cameron-Smith, D. Comparative actions of omega-3 fatty acids on in-vitro lipid droplet formation. Prostaglandins Leukot. Essent. Fatty Acids 2013, 89, 359-366.
135. Listenberger, L.L.; Han, X.; Lewis, S.E.; Cases, S.; Farese, R.V, Ory, D.S.; Schaffer, J.E. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 2003, 100, 3077-3082.
136. Bosma, M.; Hesselink, M.K.C.; Sparks, L.M.; Timmers, S.; Ferraz, M.J.; Mattijssen, F.; Schrauwen, P. Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels. Diabetes 2012, 61, 2679-2690.
137. Le Foll, C.; Corporeau, C.; Le Guen, V.; Gouygou, J.-P.; Bergé, J.-P.; Delarue, J. Long-chain n-3 polyunsaturated fatty acids dissociate phosphorylation of Akt from phosphatidylinositol 3'-kinase activity in rats. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1223-E1230.
138. Capel, F.; Acquaviva, C.; Pitois, E.; Laillet, B.; Rigaudière, J.-P.; Jouve, C.; Morio, B. DHA at nutritional doses restores insulin sensitivity in skeletal muscle by preventing lipotoxicity and inflammation. J. Nutr. Biochem. 2015, 26, 949-959.
139. Zisman, A.; Peroni, O.D.; Abel, E.D.; Michael, M.D.; Mauvais-Jarvis, F.; Lowell, B.B.; Wojtaszewski, J.F.; Hirshman, M.F.; Virkamaki, A.; Goodyear, L.J.; et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 2000, 6, 924-928.
140. Aguirre, V.; Uchida, T.; Yenush, L.; Davis, R.; White, M.F. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J. Biol. Chem. 2000, 275, 9047-9054.
141. Oh, D.Y.; Talukdar, S.; Bae, E.J.; Imamura, T.; Morinaga, H.; Fan, W.; Olefsky, J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142, 687-698.
142. Jelenik, T.; Rossmeisl, M.; Kuda, O.; Jilkova, Z.M.; Medrikova, D.; Kus, V.; Hensler, M.; Janovska, P.; Miksik, I.; Baranowski, M.; et al. AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. Diabetes 2010, 59, 2737-2746.
143. Arkan, M.C.; Hevener, A.L.; Greten, F.R.; Maeda, S.; Li, Z.-W.; Long, J.M.; Karin, M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11, 191-198.
144. Calder, P.C. Omega-3 fatty acids and inflammatory processes. Nutrients 2010, 2, 355-374.
145. Calder, P.C. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta 2014, 1851, 469-484.
146. Gregory, M.K.; Gibson, R.A.; Cook-Johnson, R.J.; Cleland, L.G.; James, M.J. Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis. PLoS ONE 2011, 6, e29662, doi:10.1371/journal.pone.0029662.
147. Lee, T.H.; Hoover, R.L.; Williams, J.D.; Sperling, R.I.; Ravalese, J.; Spur, B.W.; Austen, K.F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985, 312, 1217-1224.
148. Rees, D.; Miles, E.A.; Banerjee, T.; Wells, S.J.; Roynette, C.E.; Wahle, K.W.; Calder, P.C. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am. J. Clin. Nutr. 2006, 83, 331-342.
149. Wada, M.; DeLong, C.J.; Hong, Y.H.; Rieke, C.J.; Song, I.; Sidhu, R.S.; Yuan, C.; Warnock, M.; Schmaier, A.H.; Yokoyama, C.; et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 2007, 282, 22254-22266.
150. Mas, E.; Croft, K.D.; Zahra, P.; Barden, A.; Mori, T.A. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem. 2012, 58, 1476-1484.
151. Bannenberg, G.; Serhan, C.N. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta 2010, 1801, 1260-1273.
152. Skarke, C.; Alamuddin, N.; Lawson, J.A.; Ferguson, J.F.; Reilly, M.P.; FitzGerald, G.A. Bioactive products formed in humans from fish oils. J. Lipid Res. 2015, 56, 1808-1820.
153. Camandola, S.; Leonarduzzi, G.; Musso, T.; Varesio, L.; Carini, R.; Scavazza, A.; Poli, G. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem. Biophys. Res. Commun. 1996, 229, 643-647.
154. Vanden Berghe, W.; Vermeulen, L.; Delerive, P.; De Bosscher, K.; Staels, B.; Haegeman, G. A paradigm for gene regulation: Inflammation, NF-kappaB and PPAR. Adv. Exp. Med. Biol. 2003, 544, 181-196.
155. Shakhov, A.N.; Collart, M.A.; Vassalli, P.; Nedospasov, S.A.; Jongeneel, C.V. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med. 1990, 171, 35-47.
156. Mehra, M.R.; Lavie, C.J.; Ventura, H.O.; Milani, R.V. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J. Heart Lung Transplant. 2006, 25, 834-838.
157. Kumar, A.; Takada, Y.; Boriek, A.M.; Aggarwal, B.B. Nuclear factor-kappaB: Its role in health and disease. J. Mol. Med. (Berl.) 2004, 82, 434-448.
158. Pillon, N.J.; Arane, K.; Bilan, P.J.; Chiu, T.T.; Klip, A. Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages. Cell Commun. Signal. 2012, 10, 30, doi:10.1186/1478-811X-10-30.
159. Uysal, K.T.; Wiesbrock, S.M.; Marino, M.W.; Hotamisligil, G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389, 610-614.
160. Hotamisligil, G.; Shargill, N.; Spiegelman, B. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
161. Reinders, I.; Virtanen, J.K.; Brouwer, I.A.; Tuomainen, T.-P. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men. Eur. J. Clin. Nutr. 2012, 66, 736-741.
162. Niu, K.; Hozawa, A.; Kuriyama, S.; Ohmori-Matsuda, K.; Shimazu, T.; Nakaya, N.; Fujita, K.; Tsuji, I.; Nagatomi, R. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am. J. Clin. Nutr. 2006, 84, 223-229.
163. Thies, F.; Nebe-von-Caron, G.; Powell, J.R.; Yaqoob, P.; Newsholme, E.A.; Calder, P.C. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J. Nutr. 2001, 131, 1918-1927.
164. Varming, K.; Schmidt, E.B.; Svaneborg, N.; Møller, J.M.; Lervang, H.H.; Grunnet, N.; Dyerberg, J. The effect of n-3 fatty acids on neutrophil chemiluminescence. Scand. J. Clin. Lab. Investig. 1995, 55, 47-52.
165. Trebble, T.M.; Wootton, S.A.; Miles, E.A.; Mullee, M.; Arden, N.K.; Ballinger, A.B.; Calder, P.C. Prostaglandin E2 production and T cell function after fish-oil supplementation: Response to antioxidant cosupplementation. Am. J. Clin. Nutr. 2003, 78, 376-382.
166. Itariu, B.K.; Zeyda, M.; Hochbrugger, E.E.; Neuhofer, A.; Prager, G.; Schindler, K.; Bohdjalian, A.; Mascher, D.; Vangala, S.; Schranz, M.; et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 96, 1137-1149.
167. Kratz, M.; Kuzma, J.N.; Hagman, D.K.; van Yserloo, B.; Matthys, C.C.; Callahan, H.S.; Weigle, D.S. n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women. J. Nutr. 2013, 143, 1340-1347.
168. Gray, P.; Gabriel, B.; Thies, F.; Gray, S.R. Fish oil supplementation augments post-exercise immune function in young males. Brain Behav. Immun. 2012, 26, 1265-1272.
169. Rossmeisl, M.; Jilkova, Z.M.; Kuda, O.; Jelenik, T.; Medrikova, D.; Stankova, B.; Kristinsson, B.; Haraldsson, G.G.; Svensen, H.; Stoknes, I.; et al. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: Possible role of endocannabinoids. PLoS ONE 2012, 7, e38834, doi:10.1371/journal.pone.0038834.
170. Borkman, M.; Storlien, L.H.; Pan, D.A.; Jenkins, A.B.; Chisholm, D.J.; Campbell, L.V. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 1993, 328, 238-244.
171. Shaikh, S.R.; Rockett, B.D.; Salameh, M.; Carraway, K. Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells. J. Nutr. 2009, 139, 1632-1639.
172. Lingwood, D.; Simons, K. Lipid rafts as a membrane-organizing principle. Science 2010, 327, 46-50.
173. Altenburg, J.D.; Siddiqui, R.A. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. Mol. Cancer Res. 2009, 7, 1013-1020.
174. Williams, J.A.; Batten, S.E.; Harris, M.; Rockett, B.D.; Shaikh, S.R.; Stillwell, W.; Wassall, S.R. Docosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains. Biophys. J. 2012, 103, 228-237.
175. Kang, J.X. Omega-3: A link between global climate change and human health. Biotechnol. Adv. 2011, 29, 388-390.